Live from the NIH registry
Studies recruiting near Corpus Christi right now
Top 25 of 61 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Brusco, Corpus Christi, TX /ID# 256746 — Corpus Christi, Texas (5.3 mi)
· Sponsor: AbbVie
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
CHRISTUS Spohn Cancer Center — Corpus Christi, Texas (5.3 mi)
· Sponsor: Agendia
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Corpus Christi, Texas (5.3 mi)
· Sponsor: Akero Therapeutics, Inc
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor
Phase 3
Interventional 1,656 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 38 — Corpus Christi, Texas (5.3 mi)
· Sponsor: BioStem Technologies
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Obesity, Overweight
Phase 3
Interventional 125 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Eli Lilly and Company
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)
Phase 3
Interventional 202 participants sought
Arthritis Care of Texas — Corpus Christi, Texas (5.3 mi)
· Sponsor: EMD Serono Research & Development Institute, Inc.
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Corpus Christi, Texas (5.3 mi)
· Sponsor: AstraZeneca
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Diabetes Mellitus, Type 1
Phase 3
Interventional 300 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Eli Lilly and Company
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
Pain
N/A
Observational 4,800 participants sought
Institute of Precision Pain Medicine — Corpus Christi, Texas (5.3 mi)
· Sponsor: Boston Scientific Corporation
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Rhabdomyosarcoma
Phase 3
Interventional 342 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 1,840 participants sought
GSK Investigational Site — Corpus Christi, Texas (5.3 mi)
· Sponsor: GlaxoSmithKline
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
South Texas Clinical Research — Corpus Christi, Texas (5.3 mi)
· Sponsor: Novo Nordisk A/S
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Basal Ganglia Germinoma, Diabetes Insipidus
Phase 2
Interventional 240 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
Pinnacle Clinical Research — Corpus Christi, Texas (5.3 mi)
· Sponsor: Eccogene
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
Sjögren´s Disease
Phase 3
Interventional 570 participants sought
Arthritis Care of Texas — Corpus Christi, Texas (5.3 mi)
· Sponsor: Novartis Pharmaceuticals
Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
Chronic Pain, Intractable Pain
N/A
Interventional 70 participants sought
Institute of Precision Pain Medicine — Corpus Christi, Texas (5.3 mi)
· Sponsor: Boston Scientific Corporation
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
North American Comfilcon A Clinical Study
Astigmatism, Presbyopia
N/A
Observational 182 participants sought
Drs. McIntyre, Garza, Avila and Jurica, Optometrists — Corpus Christi, Texas (5.3 mi)
· Sponsor: CooperVision International Limited (CVIL)
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Driscoll Children's Hospital — Corpus Christi, Texas (5.3 mi)
· Sponsor: Children's Oncology Group
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Phase 3
Interventional 1,800 participants sought
Pinnacle Clinical Research - Corpus Christi — Corpus Christi, Texas (5.3 mi)
· Sponsor: Boehringer Ingelheim